Alkyl Amines Chemicals share price & results

Alkyl Amines Chemicals Limited· Chemicals· Commodities

Results to: Jun 2026
Latest analysed call: Q4 FY26
Ownership as of: Sept 2026

Global manufacturer of aliphatic amines, amine derivatives and specialty chemicals for pharma & agro.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

Metric	Value	Change	Basis	Period	Note
Revenue	528 ₹ crore	+30.0% YoY	Quarterly, as filed	Quarter to Jun 2026	Revenue from operations as filed.
Operating margin	25.0 %	+6.0 pts YoY	Operating profit / revenue	Quarter to Jun 2026	For the quarter; a change is in percentage points.
Net profit	95.0 ₹ crore	+93.9% YoY	Quarterly, as filed	Quarter to Jun 2026	Profit after tax as filed.
Return on equity	Unavailable	+16.3 ptsFY Mar 2020 vs FY Mar 2019	Trailing twelve months	TTM · period unavailable	Not in the analysed materials. No older figure is substituted.
Free cash flow margin	Unavailable	+2.3 ptsFY Mar 2020 vs FY Mar 2019	Fiscal year	FY · period unavailable	Not in the analysed materials. No older figure is substituted.
Revenue growth (YoY)	Unavailable	−20.0 ptsFY Mar 2020 vs FY Mar 2019	Trailing twelve months	TTM · period unavailable	Not in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 4 judged targets kept · 4 open · verdicts reflect calls analysed to Q4 FY26.

Alkyl Amines Chemicals Limited management guidance track record on Inve: 8 targets tracked across analysed earnings calls (1 achieved, 3 missed, 4 open).

Target	Original wording	Said	Latest call	Verdict
Acetonitrile Anti-Dumping Duty Benefit	Impact expected after 90-100 day MoF approval window Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Management confirmed that towards the end of the year, pricing and volumes for acetonitrile improved as Chinese competitors eased aggressive pricing, partially realizing the benefits of the anti-dumping duty as guided in Q2. Call transcript, Q4 FY26 · 6 May 2026	Achieved*
FY26 Volume Growth	10% to 15% double digit growth Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Management confirmed FY26 volume growth was flat, with tonnage up by only 1% YoY, missing the original 10-15% target and confirming the 'subdued' revision. Call transcript, Q4 FY26 · 6 May 2026	Missed
New Product Mechanical Completion	December 2025 or January 2026 Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Mechanical completion timeline pushed again to the end of June 2026, with commissioning now expected in early Q1 FY27. This is a further delay from the previously revised Feb-Mar 2026 target. Call transcript, Q4 FY26 · 6 May 2026	Delayed

Source: Inve Guidance Tracker for Alkyl Amines Chemicals Limited · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of Alkyl Amines Chemicals Limited's 8 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 5 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.

See the full record

Price

₹1,646.3 +0.57% · +₹9.3

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −12.0% 1Y

1Y: ₹1,871.3 on 24 Oct 2025 → ₹1,646.3. High ₹2,089.6 (26 Aug 2026), low ₹1,231.6 (30 Mar 2026).

Previous close: ₹1,637
Market cap: ₹8.4k Cr
52-week range: ₹1,231.6 – ₹2,089.6
One year: −13.54%

Overview

Symbol: NSE:ALKYLAMINE
Sector: Chemicals
Industry: Commodities
Exchange: NSE
Currency: INR

What Alkyl Amines Chemicals Limited does

Based on the company's own presentations, annual report and earnings calls.

Alkyl Amines Chemicals Limited (AACL) manufactures aliphatic amines, amine derivatives and specialty chemicals used by customers in pharmaceutical, agrochemical, dyes, rubber, surfactant and other industries to add value to their end products. It runs over 20 production plants across three manufacturing sites in Maharashtra and Gujarat, offering more than 100 products, and is a global leader or sole global producer for several of them, including synthetic Acetonitrile, DMAHCL, Triethylamine and Diethylhydroxylamine. The company earns by selling both bulk aliphatic amines and higher-value amine derivatives and specialty chemicals domestically and via exports.

Segments

Specialty Chemicals

Manufacturing sites: 3 (Patalganga, Kurkumbh, Dahej)
Installed capacity across plants: ~158,000 TPA (18,000 + 65,000 + 75,000 TPA)
Production plants: 20+ plants across three sites
Land under manufacturing: 110+ acres (Maharashtra & Gujarat)
Product portfolio: 100+ products
Export footprint: 50+ countries across six continents

Founded 1979Headquarters Vashi, Navi Mumbai, Maharashtra, IndiaEmployees 650 (FY24 (investor presentat) Company website

How the price took the results

close before → close after

Q4 FY26: +14.0%; 6 May
Q2 FY26: −1.5%; 6 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Guidance

What management said, and what became of it

1 of 4 judged targets kept · 4 open · verdicts reflect calls analysed to Q4 FY26.

Alkyl Amines Chemicals Limited management guidance track record on Inve: 8 targets tracked across analysed earnings calls (1 achieved, 3 missed, 4 open).

Target	Original wording	Said	Latest call	Verdict
Acetonitrile Anti-Dumping Duty Benefit	Impact expected after 90-100 day MoF approval window Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Management confirmed that towards the end of the year, pricing and volumes for acetonitrile improved as Chinese competitors eased aggressive pricing, partially realizing the benefits of the anti-dumping duty as guided in Q2. Call transcript, Q4 FY26 · 6 May 2026	Achieved*
FY26 Volume Growth	10% to 15% double digit growth Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Management confirmed FY26 volume growth was flat, with tonnage up by only 1% YoY, missing the original 10-15% target and confirming the 'subdued' revision. Call transcript, Q4 FY26 · 6 May 2026	Missed
New Product Mechanical Completion	December 2025 or January 2026 Call transcript, Q4 FY25 · 12 May 2025	Q4 FY25	Q4 FY26:Mechanical completion timeline pushed again to the end of June 2026, with commissioning now expected in early Q1 FY27. This is a further delay from the previously revised Feb-Mar 2026 target. Call transcript, Q4 FY26 · 6 May 2026	Delayed

Source: Inve Guidance Tracker for Alkyl Amines Chemicals Limited · to Q4 FY26

The full ledger

Open Alkyl Amines Chemicals Limited’s full ledger

A free account opens 5 company ledgers a month. All 8 tracked commitments, with each call’s wording and source.

Browse the register

Latest analysed call: Q4 FY26, 6 May 2026. 3 calls analysed.

No analysed call after Q4 FY26, though results run to Jun 2026.

Call summaries

Q4 FY26 — 6 May 2026

Alkyl Amines Q4 FY26

Alkyl Amines Chemicals Limited reported a flat top-line and bottom-line for Q4 FY26, with volumes and values remaining largely unchanged from the previous year. The company navigated significant raw material price volatility, particularly for ammonia, and managed to pass on increased costs to customers. While facing challenges from a new competitor in methylamines and a slight delay in its Kurkumbh project, management expressed cautious optimism for improved margins and 5-10% volume growth in FY27, driven by a reduction in Chinese aggressive pricing and a focus on specialty products.

Read the full call

Q2 FY26 — 6 Nov 2025

Alkyl Amines Q2 FY26

Alkyl Amines reported a subdued first half of FY26 with flat topline and marginally higher volumes, primarily due to demand pressures and geopolitical actions by the US government impacting exports and increasing Chinese competition. Despite these challenges, the company managed to retain profitability and stable gross margins. Management is optimistic about a new import-substitute product commercializing in Q1 FY26-27 and expects better performance from Acetonitrile in the coming quarters, while acknowledging an overhang in methylamine capacity.

Read the full call

Q4 FY25 — 12 May 2025

Alkyl Amines Q4 FY25

Alkyl Amines reported modest top-line growth for FY25, driven by strong volume expansion, but faced continued pricing pressure across key product segments. EBITDA margins remained stable, supported by lower raw material costs. The company's new Dahej project is on track, and while anti-dumping duties on acetonitrile have been recommended, their financial impact is pending final government approval amidst an oversupplied market.

Read the full call

Summaries of each call, in Inve’s own words; the transcript is not reproduced. Not investment advice.

Every analysed call

Alkyl Amines Chemicals Limited earnings calls (ALKYLAMINE)

Fundamentals

Ratios, each with its period

Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2015 to Mar 2020).

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
76.00 days 68.00 days 71.00 days 73.00 days 66.00 days 60.00 days

How it is calculated. Reported receivable days from the annual accounts.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
105.00 days 92.00 days 165.00 days 99.00 days 88.00 days 67.00 days

How it is calculated. Reported inventory days, using material cost / cost of goods sold.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
58.00 days 63.00 days 120.00 days 78.00 days 104.00 days 57.00 days

How it is calculated. Reported payable days, using material cost / cost of goods sold.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
123.00 days 96.00 days 116.00 days 94.00 days 51.00 days 71.00 days

How it is calculated. Reported debtor days plus inventory days less payable days.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
93.00 days 87.00 days 84.00 days 76.00 days 56.00 days 54.00 days

How it is calculated. Reported net working capital days from the annual accounts.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
18.00% 41.00% 20.00% 22.00% 19.00% 20.00%

How it is calculated. Reported dividend payout as a percentage of annual profit.
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
— — — — — —

How it is calculated. Market capitalisation from the current stock record.

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
76.00 days	68.00 days	71.00 days	73.00 days	66.00 days	60.00 days

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
105.00 days	92.00 days	165.00 days	99.00 days	88.00 days	67.00 days

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
58.00 days	63.00 days	120.00 days	78.00 days	104.00 days	57.00 days

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
123.00 days	96.00 days	116.00 days	94.00 days	51.00 days	71.00 days

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
93.00 days	87.00 days	84.00 days	76.00 days	56.00 days	54.00 days

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
18.00%	41.00%	20.00%	22.00%	19.00%	20.00%

Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
—	—	—	—	—	—

A dash means inputs are missing or too old, the ratio does not apply, or the value is outside the supported range. FY uses the reported fiscal period; TTM the latest twelve months; valuations use the current market cap with the chosen earnings period. Screen Indian stocks on these ratios →

Financials

What the filings say

Net profit, year on year: +94% (quarter to jun 2026 against jun 2025).

In ₹ crore. Oldest period first.

Line item	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	415	371	386	406	389	354	387	528
Expenses	341	301	318	329	319	287	316	394
Operating profit	74	71	68	77	70	67	71	134
Operating margin	18.0%	19.0%	18.0%	19.0%	18.0%	19.0%	18.0%	25.0%
Other income	9	7	9	8	7	8	8	9
Interest	0	0	0	0	0	0	0	0
Depreciation	18	18	18	18	18	18	18	18
Profit before tax	64	59	59	66	59	57	61	125
Tax rate	26.0%	26.0%	22.0%	25.0%	27.0%	26.0%	25.0%	24.0%
Net profit	47	44	46	49	43	42	45	95
EPS (₹ per share)	9.28	8.56	9	9.67	8.40	8.26	8.87	18.50

Source: Inve data · income statement, quarterly · to Jun 2026

In ₹ crore. Oldest period first.

Line item	Mar 2019	Mar 2020	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	846	993	1,682	1,441	1,572	1,536
Expenses	683	735	1,340	1,190	1,281	1,251
Operating profit	163	258	345	251	292	285
Other income	9	26	13	15	30	31
Interest	15	11	4	5	0	0
Depreciation	24	27	46	59	72	72
Profit before tax	134	246	308	201	248	243
Net profit	87	201	229	148	186	179

Source: Inve data · income statement, annual · to Mar 2026

In ₹ crore. Oldest period first.

Line item	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sept 2025	Mar 2026
Equity capital	10	10	10	10	10	10
Reserves	980	1,159	1,257	1,392	1,433	1,523
Borrowings	23	88	3	6	2	1
Other liabilities	359	335	314	381	322	362
Total liabilities	1,371	1,592	1,584	1,789	1,767	1,896
Fixed assets	629	719	1,089	1,044	1,039	1,015
Capital work in progress	143	352	36	52	76	130
Investments	0	0	0	0	0	51
Other assets	600	521	459	693	651	700
Total assets	1,371	1,592	1,584	1,789	1,767	1,896

Source: Inve data · balance sheet · to Mar 2026

In ₹ crore. Oldest period first.

Line item	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operations	364	205	248	275	263	239
Cash from investing	-213	-206	-277	-121	-196	-137
Cash from financing	-86	-57	8	-140	-49	-56
Net cash flow	65	-58	-21	13	18	45
Free cash flow	208	-41	-55	153	216	111

Source: Inve data · cash flow · to Mar 2026

In days and %. Oldest period first.

Line item	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	67	66	56	56	54	55
Inventory days	91	76	82	85	75	57
Days payable	133	105	84	85	80	70
Cash conversion cycle	25	36	53	56	48	42
Working capital days	26	35	28	47	42	49
Return on capital employed	56.0%	33.0%	28.0%	16.0%	19.0%	17.0%
Dividend payout	17.0%	23.0%	22.0%	34.0%	28.0%	28.0%

Source: Inve data · annual ratios · to Mar 2026

Ownership

Who owns it

Promoters hold 72.04% as of Sept 2026; institutions added 0.11 pts since Jun 2026.

Promoters 0.00 pts 72.04%
Foreign institutions −0.04 pts 3.46%
Domestic institutions +0.15 pts 3.25%
Government 0.00 pts 0.00%
Public −0.11 pts 21.25%

1,37,332 shareholders on the register.

Source: Exchange shareholding filings · to Sept 2026 · 8 filings held

Who was buying across the market this quarter

Who is on the register

Named in the Sep 2026 filing

Every holder of Alkyl Amines Chemicals Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.

Holder	Stake	Change
	57.64%	unchanged
	3.83%	unchanged
	3.81%	unchanged
	2.48%	unchanged
AIF	1.62%	unchanged
	1.54%	unchanged
	1.04%	unchanged
Mutual fund	1.02%	unchanged
	0.75%	unchanged
	0.26%	unchanged
	0.15%	unchanged
	0.15%	unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Your own record

Start an Inve Case for Alkyl Amines Chemicals Limited

Free account: one company. Everything above stays public.

Write why you follow Alkyl Amines Chemicals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Alkyl Amines Chemicals Limited

Guides on how to read this kind of business and the numbers that matter.

Performance −12.0% 1Y

What Alkyl Amines Chemicals Limited does

How the price took the results

Q4 FY26 — 6 May 2026

Q2 FY26 — 6 Nov 2025

Q4 FY25 — 12 May 2025

What the price assumes

Who is on the register

Learn to analyse Alkyl Amines Chemicals Limited